Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sickle cell disease
sickle cell disease
LentiGlobin gene therapy for sickle cell on course for filing, says bluebird
Pharmaforum
Wed, 12/11/19 - 09:50 pm
LentiGlobin
Bluebird Bio
sickle cell disease
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule
Xconomy
Mon, 11/25/19 - 10:14 pm
Global Blood Therapeutics
FDA
sickle cell disease
voxelotor
Oxbryta
Global Blood Therapeutics Goes Head to Head With Novartis On Sickle Cell
Motley Fool
Sun, 11/24/19 - 11:26 pm
Global Blood Therapeutics
voxelotor
Novartis
Adakveo
sickle cell disease
Biotech Stock Pops On Promising First In-Human CRISPR Gene-Editing Drug
Investors Business Daily
Wed, 11/20/19 - 09:53 am
CRISPR Therapeutics
gene editing
CRISPR
beta thalassemia
sickle cell disease
FDA Approves Crizanlizumab: Here Is A New Drug For Sickle Cell Disease
Forbes
Sun, 11/17/19 - 08:42 pm
Novartis
Adakveo
FDA
crizanlizumab
sickle cell disease
Novartis sickle-cell drug wins FDA approval
Biopharma Dive
Fri, 11/15/19 - 11:57 pm
FDA
Novartis
Adakveo
sickle cell disease
NIH, Gates Foundation commit $200M to cure HIV, sickle cell
Fierce Biotech
Thu, 10/24/19 - 10:18 am
NIH
Gates Foundation
HIV
sickle cell disease
Why Global Blood Therapeutics Stock Jumped 10.9% Today
Motley Fool
Thu, 09/5/19 - 08:26 pm
Global Blood Therapeutics
FDA
voxelotor
sickle cell disease
GlycoMimetics shares crash after Pfizer team dismisses their lead drug as a PhIII failure
Endpoints
Mon, 08/5/19 - 12:03 am
Pfizer
GlycoMimetics
sickle cell disease
Rivipansel
Novartis secures speedy review for sickle cell drug
Biopharma Dive
Tue, 07/16/19 - 12:05 pm
Novartis
sickle cell disease
FDA
crizanlizumab
Genetic Disease Focused Fulcrum Therapeutics Files for $86 Million IPO
CP Wire
Mon, 06/24/19 - 09:32 am
Fulcrum Therapeutics
IPOs
FSHD
sickle cell disease
beta thalassemia
Genetic Disease Focused Fulcrum Therapeutics Files for $86 Million IPO
Mon, 06/24/19 - 09:29 am
Fulcrum Therapeutics
IPOs
FSHD
sickle cell disease
beta thalassemia
GBT sickle cell trial hits endpoint ahead of NDA filing
Fierce Biotech
Fri, 06/14/19 - 10:06 am
Global Blood Therapeutics
sickle cell disease
FDA
voxelotor
Emmaus tries to move forwards by reversing
EP Vantage
Thu, 06/13/19 - 10:06 am
Emmaus Life Sciences
Endari
sickle cell disease
Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval
EP Vantage
Sat, 11/17/18 - 12:49 pm
Vertex Pharma
cystic fibrosis
Symdeko
Kalydeco
Global Blood Therapeutics
voxelotor
sickle cell disease
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Motley Fool
Tue, 10/30/18 - 11:17 pm
Novartis
crizanlizumab
sickle cell disease
Ironwood Pharmaceuticals
IW-1701
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
Xconomy
Wed, 10/10/18 - 10:49 pm
CRISPR Therapeutics
Vertex Pharmaceuticals
sickle cell disease
FDA
CTX001
Novartis drug cuts serious complications in sickle cell disease
CP WIre
Wed, 10/10/18 - 10:15 am
Novartis
sickle cell disease
crizanlizumab
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
Fierce Biotech
Wed, 06/27/18 - 12:01 pm
Global Blood Therapeutics
sickle cell disease
voxelotor
clinical trials
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
CP Wire
Fri, 06/15/18 - 10:02 am
Bluebird Bio
sickle cell disease
LentiGlobin
gene therapy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »